<p>Radiofrequency microneedling (RFMN) combines traditional microneedling with controlled radiofrequency energy to remodel the dermis and stimulate collagen production. Although minimally invasive, practitioners should understand its potential complications to ensure safe practice. Most side effects, including redness, swelling, and discomfort, resolve within one week. Post-inflammatory hyperpigmentation (PIH) represents the most clinically significant complication particularly in darker skin types (Fitzpatrick III-VI). Other rare but serious complications include persistent PIH, tram-track scarring, granulomatous reactions, and infections. Key risk factors include active skin infections, darker skin types, metal allergies, non-approved topical products, and inappropriate device settings. Absolute contraindications include active infections, inflammatory skin conditions, and pregnancy. Device selection significantly impacts safety. Insulated needles deliver energy solely to the dermis, protecting the epidermis and reducing PIH risk in darker skin. Bipolar systems create focused thermal effects and offer safer electromagnetic compatibility than monopolar systems. Treatment parameters, including energy levels, pulse duration, and needle depth, require careful adjustment based on skin type and anatomical location. Long-term data suggest sustained improvements in controlled settings, though robust evidence beyond 12 months remains limited. Management strategies include supportive care for transient effects and topical corticosteroids, sun protection, and hydroquinone for PIH. Responsible RFMN practice requires meticulous patient selection, appropriate technique, and comprehensive treatment protocols.</p>